VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Technology Scientific & Technical Instruments

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by Sonny7on Apr 08, 2016 3:29pm

68 Views

Post# 24746480

RE:RE:RE:RE:RE:RE:RE:RE:RE:90 days Trial done - no news - no trades - all dead?

In the big picture it's to anyones advantage to average down here with the share price in the toilet at the all time low. It has no place to go from here but up so unless it's a complete failure that part of it seems safe. And not many shares out with the rollback.

If if it comes to selling at a loss then that's not so bad either since it can be applied to taxes and claimed as a loss. If longs stay long then we all get paid the same price for shares as the Skidmores in a buyout scenario. Ultimately, I can see that happening.

All in all, as much as it ain't good looking, to me it's looking good. lol

Bullboard Posts

@ the Bell: TSX advances to start off Christmas trading week